Skip to content
Find a Provider
Julie E. Riccio, M.D.

Julie E. Riccio, M.D.

Pediatrics, Neonatology

UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Accepting New Patients

Contact

Office (585) 275-2972
Fax (585) 461-3614

About Me

Dr. Riccio's interest focuses on the long-term hospitalized care provided to neonates in the Neonatal Intensive Care Unit and the coordinating of care with other health care providers as these complex patients near discharge from the hospital.

Faculty Appointments

Associate Professor - Department of Pediatrics, Neonatology (SMD)

Credentials

Residency & Fellowship

Fellowship, Neonatology, University of Rochester Medical Center. 2007 - 2010

Residency, Pediatrics, SUNY Upstate University Hospital. 2004 - 2007

Internship, Pediatrics, SUNY Upstate University Hospital. 2003 - 2004

Education

MD | SUNY Upstate Medical University College of Medicine. 2003

Awards

Strong Star for excellence in exceptional service and displaying compassion, URMC. 2016

Strong Star for excellence in exceptional service and displaying compassion, URMC. 2014

Strong Star for excellence in exceptional service and displaying compassion, URMC. 2013

Strong Star for excellence in exceptional service and displaying compassion, URMC. 2011

Excellence as a Teacher Award. 2006

Excellence as a Teacher Award. 2005

Pediatric Emergency Department Resident Award. 2005

Phi Beta Kappa. 1998

Research

Dr. Riccio focuses on patent ductus arteriosus in premature neonates. Her prior work assessed the use of Ibuprofen versus indomethacin for medical treatment of PDA among level 3 NICU's across the United States. She also studied the effect of Ibuprofen, used for closure of the PDA, on bilirubin-album...
Dr. Riccio focuses on patent ductus arteriosus in premature neonates. Her prior work assessed the use of Ibuprofen versus indomethacin for medical treatment of PDA among level 3 NICU's across the United States. She also studied the effect of Ibuprofen, used for closure of the PDA, on bilirubin-albumin binding.

She is now piloting a study with a subset of NRN sites, headed by the Children's Hospital of Philadelphia. This pilot reviews the incidence and natural history of vocal cord injury after PDA ligation in premature infants. Dr. Riccio also serves as a sub-investigator with a study, Noninvasive Optical Brain Imaging of Infants Born Prematurely, for which Lauren Emberson, PhD, and Richard Aslin, PhD, of UR's Department of Brain and Cognitive Sciences, manage follow up activities after discharge.